Multipl Skleroz Tanılı Bireylerde Subjektif Yorgunluk Değerlendirme Yöntemleri: Derleme

Yıl 2024, Sayı: 2, 66 - 75, 30.09.2024

Aslı Demirtaş , İlke Keser

Öz

Multipl Skleroz’a özgü yorgunluk fiziksel aktivite ile artan ve dinlenme ile azalan bir karakter gösterebildiği gibi, dinlenme ve uyumakla dahi geçmeyen bir karakter kazanarak patolojik yorgunluk haline gelebilir. Hastalığa özgü yorgunluk algısını etkileyen faktörlerin anlaşılabilmesi için daha detaylı sınıflandırmalar yapılmaktadır. Fizyolojik ve patolojik yorgunluk olarak sınıflandırılabileceği gibi kaynağına (santral veya periferal yorgunluk), süresine (akut ve kronik yorgunluk), lokalizasyonuna (genel veya lokal yorgunluk) ve ortaya çıkış nedenine (primer veya sekonder yorgunluk) göre çeşitli başlıklar altında da incelenebilir. Multipl Skleroz’a özgü yorgunluğun yaygın olarak kabul edilen bir tanımının bulunmaması ve birçok boyutunun olması değerlendirilmesini zorlaştırmaktadır. Bu nedenle hastalarda araştırılmak istenen faktöre ve pratik uygulanabilirliğine göre bir veya birden fazla ölçek kullanılması çalışmalarda ya da klinikte yorgunluğu çok boyutlu olarak değerlendirmek için tercih edilebilir. Bu derleme ile yorgunluğu değerlendirmek için geliştirilen ölçeklerin Türkçe adaptasyon, geçerlik ve güvenirlik çalışmaları yapılıp yapılmadığı, ölçeklerin soru sayısı ve alt boyutları, özellikleri ve ek bilgilerini araştırılarak detaylı olarak incelendi.

Anahtar Kelimeler

Multipl Skleroz, subjektif, değerlendirme, ölçek.

Etik Beyan

Yazar(lar) bu makalenin araştırması, yazarlığı ve/veya yayını ile ilgili olarak herhangi bir potansiyel çıkar çatışması beyan etmemişlerdir.

Destekleyen Kurum

Yok.

Teşekkür

Yok.

SUBJECTIVE FATIGUE ASSESSMENT METHODS IN INDIVIDUALS WITH MULTIPLE SCLEROSIS: REVIEW

Öz

Multiple Sclerosis-specific fatigue may show a character that increases with physical activity and decreases with rest, or it may become pathological fatigue by acquiring a character that does not pass even with rest and sleep. In order to understand the factors affecting the perception of fatigue specific to the disease, more detailed classifications are made. It can be classified as physiological and pathological fatigue, and can also be examined under various headings according to its source (central or peripheral fatigue), duration (acute or chronic fatigue), localisation (general or local fatigue) and cause of occurrence (primary or secondary fatigue). The fact that there is no widely accepted definition of fatigue specific to Multiple Sclerosis and that it has many dimensions makes it difficult to evaluate. For this reason, the use of one or more scales according to the factor to be investigated in patients and practical applicability may be preferred to evaluate fatigue multidimensionally in studies or in the clinic. In this review, the Turkish adaptation, validity and reliability studies of the scales developed to evaluate fatigue, the number of questions and sub-dimensions of the scales, their features and additional information were examined in detail.

Anahtar Kelimeler

Multiple Sclerosis, subjective, assessment, scale.

Kaynakça

• Younger DS. Multiple sclerosis: Motor dysfunction. Handb Clin Neurol 2023;196:119-147. doi: 10.1016/B978-0-323-98817-9.00016-8. P
• Filser M, Buchner A, Fink GR, Gold SM, Penner IK. The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools. J Neurol 2023;270(1):171-207. doi: 10.1007/s00415-022-11359-6.
• Li C, Lin J, Yang T, Xiao Y, Jiang Q, Shang H. Physical activity and risk of multiple sclerosis: A Mendelian randomization study. Front Immunol. 2022 Sep 21;13:872126. doi: 10.3389/fimmu.2022.872126.
• Elbers RG, Rietberg MB, van Wegen EE, Verhoef J, Kramer SF et al. Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: A systematic review of measurement properties. Qual Life Res 2012;21(6):925-44. doi: 10.1007/s11136-011-0009-2.
• Nagaraj K, Taly AB, Gupta A, Prasad C, Christopher R. Prevalence of fatigue in patients with multiple sclerosis and its effect on the quality of life. J Neurosci Rural Pract 2013;4(3):278-82. doi: 10.4103/0976-3147.118774.
• Rottoli M, La Gioia S, Frigeni B, Barcella V. Pathophysiology, assessment and management of multiple sclerosis fatigue: an update. Expert Rev Neurother 2017;17(4):373-379. doi: 10.1080/14737175.2017.1247695.
• Penner IK, Paul F. Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol 2017;13(11):662-675. doi: 10.1038/nrneurol.2017.117.
• Buesa-Estelléz A, Cano-de-la-Cuerda R, Ortiz-Gutiérrez RM, Palacios-Ceña D. The impact of pharmacological treatment on patients with multiple sclerosis. Disabil Health J 2019;12(4):615-621. doi: 10.1016/j.dhjo.2019.05.005.
• Stuke K, Flachenecker P, Zettl UK, Elias WG, Freidel M et al. Symptomatology of MS: results from the German MS Registry. J Neurol 2009;256(11):1932-5. doi: 10.1007/s00415-009-5257-5.
• Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994;21(1):9-14.
• Dyck I, Jongbloed L. Women with multiple sclerosis and employment issues: A focus on social and institutional environments. Can J Occup Ther 2000;67(5): 337-346. doi: 10.1177/000841740006700506.
• Ayache SS, Serratrice N, Abi Lahoud GN, Chalah MA. Fatigue in Multiple Sclerosis: A review of the exploratory and therapeutic potential of non-invasive brain stimulation. Front Neurol 2022;13:813965. doi: 10.3389/fneur.2022.813965.
• Krupp LB. Fatigue in multiple sclerosis: a guide to diagnosis and management. Demos Medical Publishing 2004;15-31.
• Michielsen HJ, De Vries J, Van Heck GL, Van de Vijver FJ, Sijtsma K. Examination of the dimensionality of fatigue. Eur J Psychol Assess, 2004; 20(1): 39-48.
• Finsterer J, Mahjoub SZ. Fatigue in healthy and diseased individuals. Am J Hosp Palliat Care 2014;31(5):562-75. doi: 10.1177/1049909113494748.
• Newland P, Starkweather A, Sorenson M. Central fatigue in multiple sclerosis: a review of the literature. J Spinal Cord Med 2016;39(4):386-99. doi: 10.1080/10790268.2016.
• Bol Y, Duits AA, Hupperts RM, Vlaeyen JW, Verhey FR. The psychology of fatigue in patients with multiple sclerosis: a review. J Psychosom Res 2009;66(1):3-11. doi: 10.1016/j.jpsychores.2008.05.003.
• Rudroff T, Kindred JH, Ketelhut NB. Fatigue in Multiple Sclerosis: Misconceptions and future research directions. Front Neurol 2016;7:122. doi: 10.3389/fneur.2016.00122.
• Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology 2013;80(4):409-16. doi: 10.1212/WNL.0b013e31827f07be.
• Beckerman H, Eijssen IC, van Meeteren J, Verhulsdonck MC, de Groot V. Fatigue profiles in patients with Multiple Sclerosis are based on severity of fatigue and not on dimensions of fatigue. Sci Rep 2020;10(1):4167. doi: 10.1038/s41598-020-61076-1.
• Weiland TJ, Jelinek GA, Marck CH, Hadgkiss EJ, van der Meer DM et al. Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet. PLoS One 2015;10(2):e0115541. doi: 10.1371/journal.pone.0115541.
• Kaya G, Ergin G. Nörolojik hastalıklarda yorgunluk ve değerlendirme yöntemleri. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 2021;6(3): 171-178.
• Krupp LB, Serafin DJ, Christodoulou C. Multiple sclerosis-associated fatigue. Expert Rev Neurother 2010;10(9):1437-47. doi: 10.1586/ern.10.99.
• DeLuca J, Genova HM, Capili EJ, Wylie GR. Functional neuroimaging of fatigue. Phys Med Rehabil Clin N Am 2009;20(2):325-37. doi: 10.1016/j.pmr.2008.12.007.
• Patejdl R, Zettl UK. The pathophysiology of motor fatigue and fatigability in multiple sclerosis. Front Neurol 2022;13:891415. doi: 10.3389/fneur.2022.891415.
• Özakbaş S. Multipl Sklerozda semptomatik tedavi. Noro Psikiyatr Ars 2011;48.
• Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994;18 Suppl 1:S79-83. doi: 10.1093/clinids/18.supplement_1.s79.
• D'Souza E. Modified Fatigue Impact Scale - 5-item version (MFIS-5). Occup Med (Lond) 2016;66(3):256-7. doi: 10.1093/occmed/kqv106.
• Meads DM, Doward LC, McKenna SP, Fisk J, Twiss J et al. The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS). Mult Scler 2009;15(10):1228-38. doi: 10.1177/1352458509106714.
• Thomas S, Kersten P, Thomas PW. The Multiple Sclerosis-Fatigue Self- Efficacy (MS-FSE) scale: initial validation. Clin Rehabil 2015;29(4):376-87. doi: 10.1177/0269215514543702.
• Mills RJ, Young CA, Pallant JF, Tennant A. Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS). Health Qual Life Outcomes 2010;8:22. doi: 10.1186/1477-7525-8-22.
• Cook KF, Bamer AM, Roddey TS, Kraft GH, Kim J et al. A PROMIS fatigue short form for use by individuals who have multiple sclerosis. Qual Life Res 2012;21(6):1021-30. doi: 10.1007/s11136-011-0011-8.
• Penson A, van Deuren S, Worm-Smeitink M, Bronkhorst E, van den Hoogen FHJ et al. Short fatigue questionnaire: Screening for severe fatigue. J Psychosom Res 2020;137:110229. doi: 10.1016/j.jpsychores.2020.
• Cozart JS, Strober L, Ruppen S, Bradish T, Belcher C et al. A quick assessment of reliable change in fatigue: Reliable change indices of the modified fatigue impact scale - 5 item (MFIS-5). Mult Scler Relat Disord 2021;49:102743. doi: 10.1016/j.msard.2021.102743.
• Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 2004;56(2):157-70. doi: 10.1016/S0022-3999(03)00371-4.
• Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46(10):1121-3. doi: 10.1001/archneur.1989.00520460115022.
• Armutlu K, Korkmaz NC, Keser I, Sumbuloglu V, Akbiyik DI et al. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res 2007;30(1):81-5. doi: 10.1097/MRR.0b013e3280146ec4.
• Iriarte J, Katsamakis G, de Castro P. The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis. Mult Scler 1999;5(1):10-6. doi: 10.1177/135245859900500103.
• Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res 1991;36(3):291-298. doi: 10.1016/0165-1781(91)90027-m.
• Miró J, Sánchez-Rodríguez E, Brijaldo S, Jensen MP. The Silhouettes Fatigue Scale: comprehensibility and validity in older individuals. Disabil Rehabil 2020;42(13):1906-1911. doi: 10.1080/09638288.2018.1539129.
• Cüce İ, Altun Y. Validity and reliability characteristics of the Silhouettes Fatigue Scale in measuring multiple sclerosis-related fatigue in Turkish-speaking adults. Acta Neurol Scand 2022;146(5):671-679. doi: 10.1111/ane.13708.
• Armutlu K, Keser İ, Korkmaz N, Akbıyık Dİ, Sümbüloğlu V et al. Psychometric study of Turkish version of Fatigue Impact Scale in multiple sclerosis patients. J Neurol Sci 2007;255(1-2):64-8. doi: 10.1016/j.jns.2007.01.073.
• Ritvo PG, Fischer JS, Miller DM, Andrews H, Paty DW et al. Multiple sclerosis quality of life inventory: a user’s manual. New York: National Multiple Sclerosis Society 1997;65.
• D’Souza E. Modified Fatigue Impact Scale - 5-item version (MFIS-5). Occup Med (Lond) 2016;66(3):256-7. doi: 10.1093/occmed/kqv106.
• Michielsen HJ, de Vries J, van Heck GL, van de Vijver FJ, Sijtsma K. Examination of the dimensionality of fatigue. Eur J Psychol Assess 2004; 20(1): 39-48.
• Ozkeskin M, Özden F, Yüceyar N. The reliability and validity of the Turkish version of the fatigue assessment scale in patients with multiple sclerosis. Neurological Sciences and Neurophysiology 2022;39(2):109-114.
• Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39(3):315-25. doi: 10.1016/0022-3999(94)00125-o.
• Başoğlu F, Öncü J, Kuran B, Alptekin HK. The reliability and validity of The Turkish version of Multidimensional Fatigue Inventory-20 for the evaluation of different dimensions of fatigue in patients with fibromyalgia. Turk J Phys Med Rehabil 2020;66(4):436-443. doi: 10.5606/tftrd.2020.5781.
• Benito-León J, Martínez-Martín P, Frades B, Martínez-Ginés ML, De Andrés C et al. Impact of fatigue in Multiple Sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS). Mult Scler 2007;13(5):645-51. doi: 10.1177/1352458506073528.
• Cohen ET, Matsuda PN, Fritz NE, Allen DD, Yorke AM et al. Self-Report measures of Fatigue for people with Multiple Sclerosis: A systematic review. J Neurol Phys Ther 2024;48(1):6-14. doi: 10.1097/NPT.0000000000000452.
• Greenhalgh J. An assessment of the feasibility and utility of the MS symptom and impact diary (MSSID). Qual Life Res 2005;14(5):1363-74. doi: 10.1007/s11136-004-5389-0.
• Penner IK, Raselli C, Stöcklin M, OpwisK, Kappos L et al. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler 2009;15(12):1509-17. doi: 10.1177/1352458509348519.
• Beurskens AJ, Bültmann U, Kant I, Vercoulen JH, Bleijenberg G et al. Fatigue among working people: validity of a questionnaire measure. Occup Environ Med 2000;57(5):353-7. doi: 10.1136/oem.57.5.353.
• Ergin G, Yildirim Y. A validity and reliability study of the Turkish Checklist Individual Strength (CIS) questionnaire in musculoskeletal physical therapy patients. Physiother Theory Pract 2012;28(8):624-32. doi: 10.3109/09593985.2011.654321.
• Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S et al. Development of a fatigue scale. J Psychosom Res 1993;37(2):147-53. doi: 10.1016/0022-3999(93)90081-p.
• Belza BL, Henke CJ, Yelin EH, Epstein WV, Gilliss CL. Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 1993;42(2):93-9.
• Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res 1993;37(7):753-62. doi: 10.1016/0022-3999(93)90104-n.
• Hudgens S, Schüler R, Stokes J, Eremenco S, Hunsche E et al. Development and validation of the FSIQ-RMS: A new patient-reported questionnaire to assess symptoms and ımpacts of fatigue in relapsing Multiple Sclerosis. Value Health 2019;22(4):453-466. doi: 10.1016/j.jval.2018.11.007.
• Adın RM, Ceren AN, Salcı Y, Fil Balkan A, Armutlu K et al. Dimensionality, psychometric properties, and population-based norms of the Turkish version of the Chalder Fatigue Scale among adults. Health Qual Life Outcomes 2022;20(1):161. doi: 10.1186/s12955-022-02074-x.
• Yildirim Y, Ergin G. A validity and reliability study of the Turkish Multidimensional Assessment of Fatigue (MAF) scale in chronic musculoskeletal physical therapy patients. J Back Musculoskelet Rehabil 2013;26(3):307-16. doi: 10.3233/BMR-130385.